Skip to main content
. 2015 Feb 26;3(3):515–521. doi: 10.3892/mco.2015.519

Table I.

Characteristics of the patients treated with repeated HSV-tk + GCV injections.

Patient Age, years PSA, ng/ml Clinical stage Gleason score
Pt1 70 13.7 T2c 3+3
Pt2 63 6.6 T2b 3+5
Pt3 60 44.1 T2c 4+3
Pt4 68 7.8 T2b 4+3
Pt5 71 28.9 T2b 3+3

HSV-tk, herpes simplex virus-thymidine kinase; GCV, ganciclovir; PSA, prostate-specific antigen.